{"id":"https://openalex.org/W2092944667","doi":"https://doi.org/10.2165/00003088-198409020-00005","title":"The Influence of Obesity on the Pharmacokinetics of Oral Alprazolam and Triazolam","display_name":"The Influence of Obesity on the Pharmacokinetics of Oral Alprazolam and Triazolam","alternate_titles":[],"publication_year":1984,"publication_date":"1984-03-01","ids":{"openalex":"https://openalex.org/W2092944667","doi":"https://doi.org/10.2165/00003088-198409020-00005","mag":"2092944667","pmid":"https://pubmed.ncbi.nlm.nih.gov/6143633"},"language":"en","primary_location":{"id":"doi:10.2165/00003088-198409020-00005","doi":"https://doi.org/10.2165/00003088-198409020-00005","is_oa":false,"landing_page_url":"https://doi.org/10.2165/00003088-198409020-00005","pdf_url":null,"source":{"id":"https://openalex.org/S69290020","display_name":"Clinical Pharmacokinetics","issn_l":"0312-5963","issn":["0312-5963","1179-1926"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacokinetics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2092944667"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Darrell R. Abernethy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1290900354","display_name":"Tufts Medical Center","ror":"https://ror.org/002hsbm82","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1290900354"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Darrell R. Abernethy","raw_affiliation_strings":["Division of Clinical Pharmacology, Departments of Psychiatry and Medicine, Tufts-New England Medical Center, Box 1007, 171 Harrison Avenue, Boston, Massachusetts, 02111, USA","The Upjohn Co., Kalamazoo, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Pharmacology, Departments of Psychiatry and Medicine, Tufts-New England Medical Center, Box 1007, 171 Harrison Avenue, Boston, Massachusetts, 02111, USA","institution_ids":["https://openalex.org/I1290900354"]},{"raw_affiliation_string":"The Upjohn Co., Kalamazoo, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087737186","display_name":"David J. Greenblatt","orcid":"https://orcid.org/0000-0003-4719-6226","observed_orcids":["https://orcid.org/0000-0003-4719-6226"]},"institutions":[{"id":"https://openalex.org/I1290900354","display_name":"Tufts Medical Center","ror":"https://ror.org/002hsbm82","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1290900354"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David J. Greenblatt","raw_affiliation_strings":["Division of Clinical Pharmacology, Departments of Psychiatry and Medicine, Tufts-New England Medical Center, Box 1007, 171 Harrison Avenue, Boston, Massachusetts, 02111, USA","The Upjohn Co., Kalamazoo, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Pharmacology, Departments of Psychiatry and Medicine, Tufts-New England Medical Center, Box 1007, 171 Harrison Avenue, Boston, Massachusetts, 02111, USA","institution_ids":["https://openalex.org/I1290900354"]},{"raw_affiliation_string":"The Upjohn Co., Kalamazoo, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085911565","display_name":"Marcia Divoll","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1290900354","display_name":"Tufts Medical Center","ror":"https://ror.org/002hsbm82","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1290900354"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marcia Divoll","raw_affiliation_strings":["Division of Clinical Pharmacology, Departments of Psychiatry and Medicine, Tufts-New England Medical Center, Box 1007, 171 Harrison Avenue, Boston, Massachusetts, 02111, USA","The Upjohn Co., Kalamazoo, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Pharmacology, Departments of Psychiatry and Medicine, Tufts-New England Medical Center, Box 1007, 171 Harrison Avenue, Boston, Massachusetts, 02111, USA","institution_ids":["https://openalex.org/I1290900354"]},{"raw_affiliation_string":"The Upjohn Co., Kalamazoo, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030876540","display_name":"Randall B. Smith","orcid":"https://orcid.org/0000-0003-4262-4279","observed_orcids":["https://orcid.org/0000-0003-4262-4279"]},"institutions":[{"id":"https://openalex.org/I1290900354","display_name":"Tufts Medical Center","ror":"https://ror.org/002hsbm82","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1290900354"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Randall B. Smith","raw_affiliation_strings":["Division of Clinical Pharmacology, Departments of Psychiatry and Medicine, Tufts-New England Medical Center, Box 1007, 171 Harrison Avenue, Boston, Massachusetts, 02111, USA","The Upjohn Co., Kalamazoo, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Pharmacology, Departments of Psychiatry and Medicine, Tufts-New England Medical Center, Box 1007, 171 Harrison Avenue, Boston, Massachusetts, 02111, USA","institution_ids":["https://openalex.org/I1290900354"]},{"raw_affiliation_string":"The Upjohn Co., Kalamazoo, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055898939","display_name":"Richard I. Shader","orcid":"https://orcid.org/0000-0002-1888-7565","observed_orcids":["https://orcid.org/0000-0002-1888-7565"]},"institutions":[{"id":"https://openalex.org/I1290900354","display_name":"Tufts Medical Center","ror":"https://ror.org/002hsbm82","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1290900354"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Richard I. Shader","raw_affiliation_strings":["Division of Clinical Pharmacology, Departments of Psychiatry and Medicine, Tufts-New England Medical Center, Box 1007, 171 Harrison Avenue, Boston, Massachusetts, 02111, USA","The Upjohn Co., Kalamazoo, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Pharmacology, Departments of Psychiatry and Medicine, Tufts-New England Medical Center, Box 1007, 171 Harrison Avenue, Boston, Massachusetts, 02111, USA","institution_ids":["https://openalex.org/I1290900354"]},{"raw_affiliation_string":"The Upjohn Co., Kalamazoo, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1290900354"],"apc_list":{"value":4990,"currency":"USD","value_usd":4990},"apc_paid":null,"fwci":3.93,"has_fulltext":false,"cited_by_count":109,"citation_normalized_percentile":{"value":0.94722145,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"9","issue":"2","first_page":"177","last_page":"183"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9262999892234802,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9262999892234802,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10436","display_name":"Anesthesia and Sedative Agents","score":0.023499999195337296,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.01549999974668026,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.996999979019165},{"id":"https://openalex.org/keywords/alprazolam","display_name":"alprazolam","score":0.9739999771118164},{"id":"https://openalex.org/keywords/triazolam","display_name":"triazolam","score":1.0},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9089999794960022},{"id":"https://openalex.org/keywords/oral-clearance","display_name":"oral clearance","score":0.9300000071525574},{"id":"https://openalex.org/keywords/elimination-half-life","display_name":"elimination half-life","score":0.996999979019165},{"id":"https://openalex.org/keywords/plasma-protein-binding","display_name":"plasma protein binding","score":0.9810000061988831},{"id":"https://openalex.org/keywords/steady-state-concentration","display_name":"steady-state concentration","score":0.5839999914169312},{"id":"https://openalex.org/keywords/dose-adjustment","display_name":"dose adjustment","score":0.6150000095367432},{"id":"https://openalex.org/keywords/body-weight","display_name":"body weight","score":0.5130000114440918}],"concepts":[{"id":"https://openalex.org/C2779738154","wikidata":"https://www.wikidata.org/wiki/Q412143","display_name":"Triazolam","level":4,"score":0.9940383434295654},{"id":"https://openalex.org/C2777196872","wikidata":"https://www.wikidata.org/wiki/Q319877","display_name":"Alprazolam","level":3,"score":0.9515811204910278},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.67823326587677},{"id":"https://openalex.org/C139254425","wikidata":"https://www.wikidata.org/wiki/Q1332167","display_name":"Volume of distribution","level":3,"score":0.6145078539848328},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5963950157165527},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.4794436991214752},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4344545006752014},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.42120304703712463},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.358151376247406},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3516867160797119},{"id":"https://openalex.org/C2778173252","wikidata":"https://www.wikidata.org/wiki/Q83871","display_name":"Benzodiazepine","level":3,"score":0.26648586988449097},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000525","descriptor_name":"Alprazolam","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008657","descriptor_name":"Metabolic Clearance Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D014229","descriptor_name":"Triazolam","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.2165/00003088-198409020-00005","doi":"https://doi.org/10.2165/00003088-198409020-00005","is_oa":false,"landing_page_url":"https://doi.org/10.2165/00003088-198409020-00005","pdf_url":null,"source":{"id":"https://openalex.org/S69290020","display_name":"Clinical Pharmacokinetics","issn_l":"0312-5963","issn":["0312-5963","1179-1926"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacokinetics","raw_type":"journal-article"},{"id":"pmid:6143633","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6143633","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacokinetics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9922999739646912,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W74649421","https://openalex.org/W102728013","https://openalex.org/W127412036","https://openalex.org/W1979886938","https://openalex.org/W2007922707","https://openalex.org/W2024185962","https://openalex.org/W2045816425","https://openalex.org/W2079686372","https://openalex.org/W2091016054","https://openalex.org/W2128270899","https://openalex.org/W2143981328","https://openalex.org/W2255151157","https://openalex.org/W2411361177","https://openalex.org/W2612758649","https://openalex.org/W4252990426"],"related_works":["https://openalex.org/W2334434379","https://openalex.org/W2078544465","https://openalex.org/W2068565772","https://openalex.org/W2010830306","https://openalex.org/W2065688557","https://openalex.org/W2091016054","https://openalex.org/W1967625537","https://openalex.org/W2050686305","https://openalex.org/W2077014755","https://openalex.org/W4281710723"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2092944667","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":5},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
